BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $163,300 | -9.4% | 6,790 | +20.3% | 0.01% | 0.0% |
| Q2 2023 | $180,181 | +18.1% | 5,643 | +13.2% | 0.01% | +16.7% |
| Q1 2023 | $152,579 | -31.0% | 4,983 | 0.0% | 0.01% | -33.3% |
| Q4 2022 | $221,195 | -6.7% | 4,983 | 0.0% | 0.01% | -18.2% |
| Q3 2022 | $237,000 | +28.8% | 4,983 | +4.5% | 0.01% | +37.5% |
| Q2 2022 | $184,000 | -18.9% | 4,767 | +20.5% | 0.01% | 0.0% |
| Q1 2022 | $227,000 | -27.9% | 3,956 | 0.0% | 0.01% | -27.3% |
| Q4 2021 | $315,000 | -5.1% | 3,956 | +3.5% | 0.01% | -8.3% |
| Q3 2021 | $332,000 | -30.0% | 3,821 | +3.7% | 0.01% | -29.4% |
| Q2 2021 | $474,000 | +77.5% | 3,684 | +10.2% | 0.02% | +70.0% |
| Q1 2021 | $267,000 | -2.2% | 3,342 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $273,000 | +268.9% | 3,342 | +11.0% | 0.01% | +333.3% |
| Q3 2020 | $74,000 | +155.2% | 3,011 | +186.8% | 0.00% | +200.0% |
| Q2 2020 | $29,000 | +52.6% | 1,050 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $19,000 | – | 1,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |